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Radiosensi tizing E旺ectof Misonidazole in Radiotherapy 
for Intracranial Tumors 
SHIN-ICHI OTSUKA 
Department of Neurosurgery, Kyoto University Medical School 
(Director: Prof. Dr. HAJIME HANDA) 
The radiosensitizing effect of misonidazole was studied in an experimental system of intra-
cranially transplanted 203-glioma in C57BL mice. When 5×105 tumor cells were transplanted, 
al the control mice died within 3 weeks. When the intracranial tumor-bearing mice were treated 
10 days after transplantation‘the mean survival time of mice treated by single dose of radiation 
(1000 rad) with misonidazole (20 mg) was longer (about 6.5 weeks) than that of the mice treated 
by irradiation alone (about 4.5 weeks). In the terminal stage when the tumors were assumed to 
contain a large number of hypoxic tumor cels, intracranial tumors were removed immediately 
after irradiation with or without misonidazole treatment. Then, 5×105 viable tumor cels were 
retransplanted into other groups of mice. While al the mice retransplanted with tumor cels 
treated by irradiation alone died of tumor growth within 5 weeks, those retransplanted with tumor 
cells treated by irradiation and misonidazole remained free of tumor and survived for the ob-
ぽrvationperiod of 8 weeks. These results confirmed the radiosensitizing effect of misonidazole. 
As a clinical trial, misonidazole was given to 27 patients with brain tumors in an oral dose of 
1.0 g/m2 twice a week, 0.5 g/m2 5 times a week or 2.0 g/m2 once a week. The total dose was 
limited to 10 g/m2. Because the series of patients was not large enough and because the observ-
ation period was not long enough, it was difficult to distinguish the effect of misonidazole from 
that of conventional radiotherapy. There was no remarkable sid巴 effectsdue to misonidazole 
except for nausea and vomiting in 9 patients. However. it was thought logical to increase local 
concentration of misonidazole to enhance the radiosensitizing effect. In the next step, local 
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administration of misonidazole was studied by the use of pellet made with silicone rubber or 
silicone tube. In in vitro examination, constant release of misonidazole into saline solution at 
37oc was observed for about one month and the concentration of misonidazole was muけihigher 
(3.5 mg/ml) than the serum concentration (30 μ,g/ml) obtained by the oral administration・ In
in vivo examination, the release of misonidazole from the pellet placed in the subcutaneous tumor 
in rats was observed for 4 weeks although the concentration was not so high as had been expected 
from the data in in vitro experiments. With regard to neurotoxicity of misonidazole, when 
0.6 mg of misonidazole was injected into subarachnoid space in rats or intracranially in mice. no 
convulsion and no other neurological findings were observed. When the pellet containing 0.5 g 
of misonidazole was placed intracranially or 20 mg of misonidazole were injected into the right 
frontal lobe in dogs、noconvulsion and no other neurological findings were observed in a period 
of 7-37 days. As a clinical trial噌 threepatients with brain tumors have been treated by the local 
application of misonidazole pellet into the tumor bed as an adjunct to radiotherapy. Although 
it is too early to make a conclusion, there have been no remarkable side effects and al of them 
have had an uneventful clinical course for 3ー7months. In order to get much stronger anti tumor 
efect, the effect of misonidazole used with anti cancer drugs or hyperthermia should be studied, 






























るため， siliconerubber, silicone tubeより薬剤が持続
的に放出される18,25，聞ととを利用して misonidazole

















































蕩移植後10日目の7 ウスlζ ＂Co照射を行ない， miso-
nidazoleを投与した群と投与しない群とで， 7ウスの
生存期間を比較検討した．第3！ζ腫蕩移植後第3週自
にはいり terminalstageにある7 ウスでは， hypoxic
cellsの占める割合が相対的に多いと考えられるが，
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Fig. 1. メurvivalrate九ofC57BL mice with intracranially transplanted 203-glioma in 
relation to the number of tumor cells transplanted. 
・-. -・ 1×106, ・一一一.5×105, ・－ ・2.5×105, x一－x1 × 10• 
Each group consisted of 12 mice. 
A dose of 5×105 tumor cells was used in al the following experiments. 
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Fig. 2. Radiosensitizing effect of misonidazole on intracranially transplanted tumors 
6 days after transplantation. 
・一一・ non-treatedcontrol mice ×一ー－x mice treated with irradiation (500 rad) and misonidazole (20 mg) 
企－－・ A. mice treated with irradiation (1000 rad) alone 
・－－・ micetreated with irradiation (1000 rad) and misonidazole (20 mg) 
Each group consisted of 10 mice. 
Effect of misonidazole was minimal and not statistically significant when given 







にある7 ウスの wholebrainに soco照射を行ない．
腫蕩を摘出し，新たに正常7 ウスの頭蓋内へ移植した
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Weeks after transplantation 
Fi邑.3. Radiosensitizing effect of misonidazole on intracranially transplanted tumors 
10 days after transplantation. 
．一一・ non-treatedcontrol mice 
A一日－A.mice treated with irradiation (1000 rad alone) 
・－・ micetreated with irradiation (1000 rad) and misonidazole (20 mg) 
Each group consisted of 10 mice. 
Effect of misonidazole when given 10 days after transplantation was statisti司


















weeks alter transplantation 
Fig. 4. Radiosensitizing e仔ectof misonidazole in comparison with sole effect of irra-
diation on intracranially transplanted tumors. 
．一一一・ nontreated control mice 
・ー・ー圃 micetreated with irradiation (1000 rad) and misonidazole (20 mg) 
A.・ A. mice treated with irradiation (1500 rad) alone 
Irradiation and misonidazole were administered 10 days after transplantation. 
Each group consisted of 10 mice. 
Effect of irradiation (1000 rad) with misonidazole (20 mg) was comparable to the 
effect of a larger dose of irradiation (1500 rad). 
5×105個を移植した7 ウスは，移植後第3週自に全例





sonidazole 投与後， •°Co 1000 rad照射を行なった後，
摘出した腫場を移植したマウスは，腫蕩は生着せず，
全例 8週間以上生存した．同実験で •oco 3000 radお
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Fig. 5. Radiosensitizing effect of misonidazole on retransplantability and growth potential 
of intracranial tumors irradiated in the terminal stage. (in vivo assay) 
・一一・ micetransplanted non-treated tumor cells 
×・・・ x mice transplanted tumor cells after prior irradiation (1000 rad) alone 
一・－ mice transplanted tumor cells after prior irradiation (1000 rad) with mi-
sonidazole (20 mg) 
Each group consisted of 10 mice. 
Transplantability and growth potential were markedly suppressed by prior irradi” 
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Fi邑.6. Changes of body weight of mice treated with irradiation and/or misonidazole. ・一 micetreated with intracranial injection of saline (10 μ.l) at the beginning 
of experiment instead of tumor cells 
0一一O mice treated with intracranial injection of saline (10 μ.l) at the beginning 
of experiment instead of tumor cells and with misonidazole (20 mg) 10 
days later 
.A. ・ ・.A. intracranial tumor bearing mice without treatment 
fr-- 6 intracranial tumor bearing mice treated with misonidazole (20 mg) ・ intracranialtumor bearing mice treated with irradiation (1000 rad) and 
misonidazole (20 mg) 
臼ーー 口ー intracranialtumor bearing mice treated with irradiation (1000 rad) 
× ・ xintracranial tumor bearing mice treated with irradiation (1500 rad) 
Irradiation and/or misonidazole were administered 10 days after transplantation. 
Each group consisted of 10 mice. 
腫場を移纏しないで， misonidazoleのみを投与した7
ウスは，体重減少は認められず，頭蓋内lζ生理食塩水
10 μl Jを注入した controlの7 ウスとほぼ同様に増加
し， misonidazole20 mg腹腔内1回投与の影響はほと








































·~ I Single dose i Total dose I Side e釘ectsI Outcome 
I of I of I of !(Interval after 
I misonidazole I misonidazole I misonidazole I diagnosi叶
I (g) ! (g) I I (months) 
! 0. 8 ; 12 : i died ( 7)
i 1. 5 : 6 ! nausea i died (13) 
0. 3 1. 5 J ! alive (37) 
1. 6 , 11. 2 i • died (12) 
1. s I 1s i I diβd ( 2)
1. 4 1 14 1 i died （幻）
1. 2 ! 10. 8 ! ! alive (33) 



























































































































































































































Fig. 7. A. misonidazole pellet made with silastic medical-grade elastomer (Dow Cormng) 
B. misonidazole pellet made with ¥Ocon s No. 4 silicone tube (Fuji system) 
























れ替えると， Fig.9 1ζ示したように， 1週間自には約
20 mg/week，以後4週間固まで約 15mg/weekのほぼ
安定した放出濃度が認められた．
2. silicone tubeを用いて作製した misonida-
zole pelletの invitroにおける放出実験
(1) 材料と方法
伊contube s. No. 4 （富士システム K.K.)K,miso-
nidazole純末 0.5gを入れ， tubeの両端を medical
adhesive silicone type A (Dow Corning K. K.）でふさ
ぎ， misonidazole pelletを作製した（Fig.7B). この
pelletを生理食塩水 2mlのはいった試験管内に入れ，





次lζ，A I¥ o. 10 silicone tube (Dow Corning K.K.) 
に， misonidazole純末2gを入れ， tubeの両端を me-








l 2 3 4 5 6 7 days 
Fig. 8. Release of misonidazole from the pellet made 
with silastic medical-grade elastomer in vitro. 
When the pellet containing 1 g of misonida-
zole was placed in 2.0 ml of normal saline 
every 24 hours, it released a larger dosis of 
misonidazole into the saline at 37°C for五rst
2 days, but it released 6 8 mg/day of mison-








10 20 30 days 
Release of misonidazole from the pellet 
made with ¥Ocon s No. 4 silicone tube in 
vitro 
When the pellet containing 0.5 g of miso 
nidazole was placed in 2.0 ml of normal 
saline every 3 days, it released 330 400 
p.g/3 days of misonidazole into the saline 
at 37°C for 30 days. 
理食塩水で洗浄後，新しい生理食塩水のはいった試験 zole pelletからの， 37°Cにおける生理食塩水中への
管内に入れ， 1週間に， 37°Cで，生理食塩水中lζ放 misonidazoleの放出濃度は， pelletを1週間ごとに新
出される misonidazoleの濃度を， 4週間にわたり測定 しい生理食塩水に入れ替えると， Fig.11に示したょ
した．次に同じ pelletを37°Cで生理食塩水中に留置 うに， 2.7～3.3mg/weekのほぼ安定した放出濃度が，
したまま，新しい生理食塩水lζ入れ替えないで， l週 4週間にわたり認められた．
間ごとに，生理食塩水中に放出される misonidazoleの 次に，同じ pelletを， 37°Cで，生理食塩水中lζ留
濃度を測定した． 置したまま，新しい生理食塩水に入れ替えない場合は，
(2）結果 Fig. 12 Iζ示したように. 1週間自の 3.2mgから， 4
¥Ocon tube s. No. 4を用いて作製した misonidazole 週間目の 11.0mgまで，漸増する放出濃度が認めら
pelletからの， 37°C における生理食塩水中への miso- れた．
nidazoleの放出濃度は， Fig.10 に示したように• 330 3. silastic medical-grade elastomerを用いて
～400 p.g/3 daysのほぼ安定した放出濃度が， 30日間 作製した misonidazolepelletの invivoに
にわたり認められた． おける放出濃度測定の実験






Fi邑.9. Release of misonidazole from the pellet made 
with silastic medical-grade elastomer in vitro. 
When the pellet containing 1 g of misonida-
zole was placed in 2.0 ml of normal saline 
every week, it released 15 20mg/week of mi-
sonidazole into the saline at 37°C for 4 weeks. 
mg/week 
一～～一一一＼～
3 4 weeks 
Fig. 11. Release of misonidazole from the pellet 
made with A. No. 10 silicone tube in vitro. 
When the pellet containing 2 g ofmison-
idazole was placed in 10 ml of normal 
saline every week, it released 2目73.3mg/ 
week of misonidazole into the saline ~ 
37。Cfor 4 weeks. 
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2 J 4 weeks 
Fig. 12. Release of misonidazole from the pellet 
made with A. No. 10 silicone tube in vitro. 
When the pellet containing 2 g ofmison-
idazole was placed in 10 ml of normal 
saline, 3.2mg of misonidazole was detected 
after a week and then the concentration 
of misonidazole in the saline gradually 
increased and 4 weeks later 11.0 mg of 
misonidazole was detected. 
(I) 材料と方法
misonidazole pelletは， silasticmedical-grade elasto-
mer 0.5 g It:, misonidazole純末 0.25gを混合して作
製したものを用いた．
使用したラットは， WistarFibiger rat 7週令雄で
ある．






















主主主~ 2-_i_: l 3 I 4 
Tumor (μ.g/g) I 24. 3 I 肌 41 I 乱 8
Cy叫 Fluid(μ.g/ml) i 25. 8 I 26. I I - I -
Serum (μ.g/ml) Iく1.01くi.01くi.olく1.0 
Liver (1-g/gl Iく1.0！くi.01 i.2iくI.0 












テノレ麻酔下で， Terumo 1 ml disposable町町torを用

























i Total dose I E百ectof I Dose of I Corripli~ns 
Cases Age Sex Histology I of I凶 o伽 apyI misonida副 elmis。品a叫
/r叫 o伽 apyl on CT I in p山 t I pellet v ' 
67 F Metastasis i 5100 rad ! stal>le i 2 g ! none 
(uterus ca) I ! I 
2 44 M G刷 astomaI 6000 rad ! stable ! 1 g ! none 
3 44 F Astrocytoma I 4山 I stable I 1 g : none 
変化を検討した． medical-grade elastomer 2 gに misonidazole1 gを混
(2）結果 合した pelletを，腫蕩摘出腔内に留置し術後に放射
マウスの頭蓋内iζmisonidazoleを注入し経過を観 線治療を行なった．放射線治療前後での CT上の放射




























3）.第1例は， A.No. 10 silicone tul>e lζmisonidazole 


























































































































に達するとして， 日本人においては， 総投与量を 10





















cone rubber, silicone tubeを用いて， misonidazole
pelletを作製し， misonidazoleの腫蕩局所投与につい
て検討した．






grade elastomerおよび siliconetu beを用いて misonト
dazole pelletを作製し， これらの pelletから misoni-
dazoleがmvitroで生理食塩水中に約1カ月にわたり，
持続的に放出されることが確認された.silicone rubber 










































































て， 7ウスの頭蓋内， ラットの大槽内へ 0.6mg注
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